Literature DB >> 1570259

NonEBV-related B-cell lymphoma in a renal transplant patient responding to acyclovir and reduction in immunosuppression.

R C Wong1, P Harrison.   

Abstract

A case of polyclonal B-cell pharyngeal lymphoma in a renal transplant patient is reported. No evidence of Epstein-Barr virus involvement was detected, but the lymphoma underwent complete remission with acyclovir and reduction in immunosuppression.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1570259      PMCID： PMC2399208          DOI： 10.1136/pgmj.68.796.145

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  5 in total

1.  Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy.

Authors:  T Beveridge; P Krupp; C McKibbin
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

2.  Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors:  T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

3.  Lymphoma and cyclosporin.

Authors:  M J Bia; W Flye
Journal:  Lancet       Date:  1984-06-23       Impact factor: 79.321

4.  Malignant lymphoma in a renal transplant patient on cyclosporin A therapy.

Authors:  R J Walker; D J Tiller; J S Horvath; G G Duggin
Journal:  Aust N Z J Med       Date:  1989-04

5.  Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

Authors:  D W Hanto; K J Gajl-Peczalska; G Frizzera; D C Arthur; H H Balfour; K McClain; R L Simmons; J S Najarian
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.